Inactief instrument

Koers Juniper Pharmaceuticals Inc

Aandelen

Duur

Periode

Stijl

Juniper Pharmaceuticals : Reports Second Quarter 2018 Financial and Operating Results	09-08-18
Dow Jones Industrial Average : Les valeurs à suivre à Wall Street	03-07-18
Juniper Pharmaceuticals : Signs Definitive Agreement to be Acquired by Catalent, Inc. for $11.50 Per Share in Cash	03-07-18
Juniper Pharmaceuticals : Reports First Quarter 2018 Financial and Operating Results	10-05-18
Juniper Pharmaceuticals : to Report First Quarter 2018 Results on May 10, 2018	01-05-18

Managers	Titel	Leeftijd	Van
Steven Fasman BRD	Director/Board Member	61	14-08-18

Besturend	Titel	Leeftijd	Van
Steven Fasman BRD	Director/Board Member	61	14-08-18
James Geraghty CHM	Chairman	70	26-05-15

Sector